Furthermore, 92.27% of patients were diagnosed with Type 2 diabetes mellitus, 73.63% had recorded insulin use, and 60% diagnosed with non-proliferative diabetic retinopathy (NPDR). This evidence concerns the gene INS and diabetes mellitus.